These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 22834121)

  • 1. [Ladasten versus placebo effect self-evaluated by neurasthenia patients with different EEG alpha rhythm types].
    Neznamov GG; Bochkarev VK; Reutova MA; Shabanova AA; Siuniakov SA
    Eksp Klin Farmakol; 2012; 75(5):7-13. PubMed ID: 22834121
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Characteristics of ladasten effect in neurasthenia patients with various EEG parameters].
    Neznamov GG; Bochkarev VK; Siuniakov SA; Grishin SA
    Eksp Klin Farmakol; 2008; 71(4):18-25. PubMed ID: 18819436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Self-evaluation of single test doses and objective indices of ladasten vs. placebo efficacy in neurasthenic patients].
    Reutova MA; Siuniakov SA; Siuniakov TS; Dorofeeva OA; Mametova LÉ; Neznamov GG
    Eksp Klin Farmakol; 2011; 74(11):6-13. PubMed ID: 22288153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ladasten, the new drug with psychostimulant and anxiolytic actions in treatment of neurasthenia (results of the comparative clinical study with placebo)].
    Neznamov GG; Siuniakov SA; Teleshova SE; Chumakov DV; Reutova MA; Siuniakov TS; Mametova LE; Dorofeeva OA; Grishin SA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2009; 109(5):20-6. PubMed ID: 19491814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Pilot clinical trial of ladasten].
    Siuniakov SA; Grishin SA; Teleshova ES; Neznamov GG; Seredenin SB
    Eksp Klin Farmakol; 2006; 69(4):10-5. PubMed ID: 16995430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Randomised, double-blind, placebo-controlled study of pivagabine in neurasthenia.
    Pizzolato G; Cagnin A; Mancia D; Caffarra P; Avanzi S; Copelli S; Ciappina C; Lo Presti F; Spilimbergo PG; D'Antonio E; Di Costanzo E; Matrango M; Pastres P; Urbani PP; Signorino M; Simoncelli M; Provinciali L; Regnicolo L; Albano C; Roccatagliata G; Rubino V; Cultrera S; Fracassi M
    Arzneimittelforschung; 1997 Nov; 47(11A):1329-31. PubMed ID: 9450159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of ladasten on the proteinase C activity in the rat brain cells].
    Vakhitova IuV; Salimgareeva MKh; Seredenin SB
    Eksp Klin Farmakol; 2004; 67(2):12-5. PubMed ID: 15188752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Use of the new psychotropic preparation bemitil in treating asthenic disorders (clinico-pharmacological research)].
    Aleksandrovskiĭ IuA; Bobkov IuG; Neznamov GG; Serebriakova TV; Boĭko SS
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1988; 88(3):109-15. PubMed ID: 3381606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of antiasthenic drug ladasten on the level of cytokines and behavior in experimental model of anxious depression in C57BL/6 male mice].
    Tallerova AV; Kovalenko LP; Durnev AD; Seredenin SB
    Eksp Klin Farmakol; 2011; 74(11):3-5. PubMed ID: 22288152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of ladasten on the psychophysiological parameters of healthy volunteers].
    Bogdan NG; Kolotilinskaia NV; Iarkova MA; Nadorov SA; Badyshtov BA; Seredenin SB
    Eksp Klin Farmakol; 2009; 72(3):3-9. PubMed ID: 19642584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A quantitative pharmaco-EEG study on psychotropic properties of cerebral metabolic enhancers: comparison between young and elderly healthy volunteers].
    Nobuhara K
    Seishin Shinkeigaku Zasshi; 1993; 95(5):392-416. PubMed ID: 8356168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Adaptive regulation of cerebral biopotentials (alpha-rhythm) in neurotic patients].
    Artemchuk NL
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(11):1539-44. PubMed ID: 516969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Brain activation levels and the significance of the stage B(I) indices in neuroses].
    Kratin IuG; Artemchuk NL; Butorina GV; Vel'shikaev RKh; Nikiforova TE
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(3):500-8. PubMed ID: 1323176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Narrow-band changes in the the EEG spectral composition under the influence of an agonist and an antagonist of noradrenergic neuromediation].
    Paniushkina SV; Kurova NS; Bochkarev VK; Avedisova AS; Martiushov AN
    Zh Vyssh Nerv Deiat Im I P Pavlova; 1992; 42(1):37-43. PubMed ID: 1316015
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychotropic effects of sidnocarb and ladasten in inbred mice with different reaction to emotional stress.
    Levina MN
    Bull Exp Biol Med; 2005 Mar; 139(3):337-9. PubMed ID: 16027847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of asthenic disorders in patients with psychoautonomic syndrome: results of a multicenter study on efficacy and safety of ladasten].
    Voznesenskaia TG; Fokina NM; Iakhno NN
    Zh Nevrol Psikhiatr Im S S Korsakova; 2010; 110(5 Pt 1):17-26. PubMed ID: 21322821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effect of nootropic substances on fluctuations in vigilance tonus in postinjury pseudoneurasthenia. EEG study].
    Strnad P; Misurec J; Strnadová V
    Cesk Neurol Neurochir; 1985 Jul; 48(4):235-9. PubMed ID: 4028234
    [No Abstract]   [Full Text] [Related]  

  • 18. [Changes in the narrow-band components of the EEG spectrum under the action of nootropic drugs].
    Paniushkina SV; Avedisova AS
    Eksp Klin Farmakol; 1992; 55(3):14-7. PubMed ID: 1458152
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Use of cortexin in adolescence neurasthenia].
    Chutko LS; Kropotov IuD; Surushkina SIu; Iakovenko EA; Nikishena IS; Livinskaia AM; Anisomova TI
    Zh Nevrol Psikhiatr Im S S Korsakova; 2006; 106(2):50-1. PubMed ID: 16548375
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects of ladasten on dopaminergic neurotransmission and hippocampal synaptic plasticity in rats.
    Mikhaylova M; Vakhitova JV; Yamidanov RS; Salimgareeva MKh; Seredenin SB; Behnisch T
    Neuropharmacology; 2007 Oct; 53(5):601-8. PubMed ID: 17854844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.